• Disease Areas
    • Diabetes
    • Obesity
    • Cardiovascular Disease (CVD)
    • Chronic Kidney Disease (CKD)
    • Metabolic Dysfunction-Associated Steatohepatitis (MASH)
    • Neurodegenerative Diseases
    • Haemophilia
    • Sickle Cell Disease
    • Primary Hyperoxaluria
    • Growth Hormone Disorders
    • Hormone Replacement Therapy
  • Congresses
  • Scientific Publications
  • IME

Register Login
My Account
Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

  • Congresses
  • European Association for the Study of the Liver (EASL 2023)
  • Prevalence of, and effect of semaglutide on, features of non-alcoholic steatohepatitis using SomaSignal tests in patients with obesity with/without type 2 diabetes, and correlation of SomaSignal tests with histology in patients with non-alcoholic steatohepatitis: analysis of data from three randomized trials
European Association for the Study of the Liver (EASL 2023)